Posts Archive

Myeloma UK Publication, intended for UK Audience Myeloma – An Introduction - Myeloma Essentials https://www.myeloma.org.uk/...

NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023 Click here to see patient's guideline book by NCCN. Presented with support from: NCCN...

www.uptodate.com - What is Multiple Myeloma? Patient education: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)...

How to Navigate through MCT Website and find high yield topics. You can also search any topic in search bar to find related posts....

Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj DARATUMUMAB (DARZALEX) NIH National cancer institute - cancer.gov...

Patient Education: Revlimid (lenalidomide) - Immunomodulatory Agents - IMIDS LENALIDOMIDE (REVLIMID) NIH National cancer institute...

Patient Education: Bortezomib (Velcade) - Proteasome Inhibitors BORTEZOMIB (VELCADE) NIH National cancer institute -cancer.gov site info...

Why is it important to become your own best advocate? Why is it important to become your own best myeloma advocate? HealthTree University...

What is a Myeloma Specialist, Why do I Need one, and How do I Find One? HealthTree University Myeloma Dec 13, 2019 Learn more: HealthTree...

The Binding Site: Freelite Overview FreeLite Overview Learn more: The Binding Site https://www.youtube.com/c/BindingSite/videos

Siteman Cancer Center: Autologous stem cell transplant at Siteman Cancer Center Siteman Cancer Center https://www.youtube.com/user/Sitema...

IMF - International Myeloma Foundation: Patient Handbook 2022 Click here to view Patient Handbook Learn more: https://www.myeloma.org/pub...

PE: CDC Guidelines - How to prevent infections (sepsis) while getting chemotherapy? Information for Patients and Caregivers | Preventing...

Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. MARCH 07, 2022 - TEL AVIV, Israel &...

National Cancer Institute: Clinical Trials Information for Patients and Caregivers National Cancer Institute: Clinical Trials Information...

Watch on You Tube Update on Multiple Myeloma Treatment: Kenneth C. Anderson, MD Jan 19, 2022 Dana-Farber Cancer Institute Learn more:...

Low ANC Count is a risk for developing infections, while getting cancer treatments. Monitoring Your ANC helps you prevent infections....

IMF Patient & Family Webinar - New Frontiers In Myeloma Care, May 14, 2022 You are central to the care team: Be Empowered Watch Video on...

Multiple Myeloma Research Foundation - MMRF - Minimal Residual Disease (MRD) | High Impact Topic HIT MRD (Minimal residual disease):...